NICE seeks compromise over Glivec approval
March 24, 2010Sales and Marketing Glivec, NICE, Novartis
NICE says it is unlikely to approve the use of Glivec against gastrointestinal stromal tumours (GISTs) after surgery, but is …
GSK breathes more easily after Sandoz exit
March 24, 2010Sales and Marketing Advair, Sandoz, generics, vectura
Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …
Vernalis diabetes pain drug fails in phase II
March 24, 2010Research and Development Vernalis
Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …
Cheaper vaccines for developing countries
March 24, 2010Vaccine, developing world, vaccines
GlaxoSmithKline and Pfizer have signed a deal to supply anti-pneumococcal drugs to developing countries at steeply discounted prices. GSK will …
Quintiles hands Geoff Owen global business development role
March 24, 2010Sales and Marketing Quintiles, appointment, sales and marketing
Contract services company Quintiles has appointed Geoff Owen to lead global business development for its Commercial group. As senior vice …
Adverse event halts Merck cancer vaccine trial
March 23, 2010Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines
Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
Virus contamination found in GSK’s Rotarix
March 23, 2010Business Services, Manufacturing and Production, Sales and Marketing Contamination, GSK, Vaccine, manufacturing compliance
The European Medicines Agency has demanded more information “as a matter of urgency” from GlaxoSmithKline over a virus in its …
Digital Pharma: The industry’s real social media question
March 23, 2010Medical Communications Janssen, digital pharma, social media
There is a tremendous amount of discussion at the moment about how trust is now the key to corporate reputation. …
Emma Walmsley to head up GSK consumer healthcare
March 23, 2010Sales and Marketing GlaxoSmithKline, appointment, consumer healthcare, sales and marketing
GlaxoSmithKline has appointed Emma Walmsley president, Consumer Healthcare Europe and president designate, Worldwide Consumer Healthcare with effect from 1 May. …
PPD boosts position in flu vaccine research
March 23, 2010Research and Development CRO, PPD, Southern Research Institute, vaccines
PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …
US House passes health reform
March 22, 2010Sales and Marketing Obama, US healthcare
The US House of Representatives has passed an historic bill which represents a major reform for America’s healthcare system. Passed …
CHMP in brief: Hospira’s Nivestim approved
March 22, 2010Research and Development EMA
A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …
Tarceva gets nod for maintenance treatment
March 22, 2010Sales and Marketing Tarceva, lung cancer
Tarceva looks set to gain approval in Europe to treat patients with non-small cell lung cancer whose disease remains stable …
The health crunch: can the NHS flourish in leaner times?
March 22, 2010NHS, NHS funding, qof
The economic downturn which hit the UK in 2009 coincided with a pre-planned slowing down in the investment in the …
Pfizer’s Kindler elected PhRMA chairman
March 22, 2010Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing
Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …
Merck joins coalition for biosecurity vaccine plant
March 22, 2010Manufacturing and Production, Research and Development biodefence, vaccines
Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …
Baxter Alzheimer’s candidate shows promise
March 20, 2010Research and Development Alzheimer's, baxter
Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …
GSK’s Relovair moves into phase III
March 19, 2010Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory
GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …
European approval for ‘double strength’ Faslodex
March 19, 2010Sales and Marketing AstraZeneca, Faslodex, breast cancer
AstraZeneca’s Faslodex has expanded its European licence after winning approval to treat women with hormone receptor-positive breast cancer in a …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
